Novartis Q3 Non-GAAP EPS of $2.46 beats by $0.22; FY core operating income outlook upgraded

Novartis Q3 earnings beat EPS estimates, missed revenue, and raised 2026 core operating income guidance.

CryptoAlerta — análise de criptomoedas e mercado em tempo real